Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BioMedWire Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1275894206469267456.png) @BioMedWire BioMedWire

BioMedWire posts on X about $azn, $mrk, india, $tzup the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1275894206469267456/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1275894206469267456/c:line/m:interactions.svg)

- X Week XXXXX +332%
- X Month XXXXX +61%
- X Months XXXXXX +34%
- X Year XXXXXX +44%

### Mentions: X [#](/creator/twitter::1275894206469267456/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1275894206469267456/c:line/m:posts_active.svg)


### Followers: XXXXX [#](/creator/twitter::1275894206469267456/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1275894206469267456/c:line/m:followers.svg)

- X Week XXXXX +0.23%
- X Month XXXXX +0.39%
- X Months XXXXX +0.70%
- X Year XXXXX +0.54%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1275894206469267456/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1275894206469267456/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1275894206469267456/influence)
---

**Social category influence**
[stocks](/list/stocks)  [countries](/list/countries)  [currencies](/list/currencies)  [technology brands](/list/technology-brands)  [cryptocurrencies](/list/cryptocurrencies)  [finance](/list/finance) 

**Social topic influence**
[$azn](/topic/$azn), [$mrk](/topic/$mrk), [india](/topic/india), [$tzup](/topic/$tzup), [microsoft](/topic/microsoft), [mounjaro](/topic/mounjaro), [$lly](/topic/$lly), [eli lilly](/topic/eli-lilly), [$beat](/topic/$beat), [acquisition](/topic/acquisition)

**Top assets mentioned**
[AstraZeneca PLC (AZN)](/topic/$azn) [Merck & Co., Inc. (MRK)](/topic/$mrk) [THUMZUP MEDIA CORP (TZUP)](/topic/$tzup) [Microsoft Corp. (MSFT)](/topic/microsoft) [Eli Lilly and Company (LLY)](/topic/$lly) [MetaBeat (BEAT)](/topic/$beat)
### Top Social Posts [#](/creator/twitter::1275894206469267456/posts)
---
Top posts by engagements in the last XX hours

"AI System Beats Doctors at Diagnosing Complicated Health Conditions Microsoft Says $TZUP #AIstocks #Doctors"  
![@BioMedWire Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1275894206469267456.png) [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1942240991626326098) 2025-07-07 15:15:12 UTC 1295 followers, XX engagements


"$LLY launches Mounjaro KwikPen in India a onceweekly prefilled injector offering six dosage strengths to help adults manage type2 diabetes and obesity: #Mounjaro #DiabetesCare #ObesityManagement #EliLilly"  
![@BioMedWire Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1275894206469267456.png) [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1938296279974531380) 2025-06-26 18:00:19 UTC 1295 followers, XXX engagements


"$AZN secures CDSCO approval for Imfinzi (durvalumab) with gemcitabinecisplatin as neoadjuvant & adjuvant therapy in muscleinvasive bladder cancer patients in India: #BladderCancer #CDSCO #Oncology #Imfinzi"  
![@BioMedWire Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1275894206469267456.png) [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1945181648934326741) 2025-07-15 18:00:19 UTC 1296 followers, XX engagements


"$AZN Baxdrostat has met both primary & secondary Phase III endpoints significantly lowering systolic BP in hardtotreat hypertension. Advancing a novel aldosteroneblocking therapy: #Baxdrostat #Hypertension #CardioRenal #AstraZeneca"  
![@BioMedWire Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1275894206469267456.png) [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1944819238847316284) 2025-07-14 18:00:14 UTC 1296 followers, XX engagements


"$MRK begins clinical trials for MK-8527 a once-monthly oral HIV PrEP candidatepotential step forward in long-acting HIV prevention: #Merck #HIVPrevention #PrEP #ClinicalTrials #HealthcareInnovation"  
![@BioMedWire Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1275894206469267456.png) [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1945121330950553629) 2025-07-15 14:00:38 UTC 1295 followers, XX engagements


"$MRK is set to begin Phase X trials for its once-monthly oral HIV prevention pill. A potential game-changer in long-acting PrEP options: #Merck #HIVPrevention #PrEP #HealthcareInnovation #PharmaNews"  
![@BioMedWire Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1275894206469267456.png) [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1945483723933143536) 2025-07-16 14:00:39 UTC 1296 followers, XX engagements


"BioMedNewsBreaks Why $BEAT Is One to Watch"  
![@BioMedWire Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1275894206469267456.png) [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1942664786623201680) 2025-07-08 19:19:12 UTC 1295 followers, XX engagements


"$AZN experimental drug for transthyretin amyloidosis did not meet its main goal in a late-stage trial dealing a setback in the race for rare disease treatments: #AstraZeneca #ClinicalTrials #PharmaNews #Biotech #HealthUpdate"  
![@BioMedWire Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1275894206469267456.png) [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1945544045796762094) 2025-07-16 18:00:21 UTC 1296 followers, XX engagements


"$MRK has closed its $3.4B acquisition of SpringWorks Therapeutics expanding its oncology pipeline and bolstering precision cancer treatments: #MerckAcquisition #Oncology #PrecisionMedicine #PharmaNews #BioPharma"  
![@BioMedWire Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1275894206469267456.png) [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1943671832885731570) 2025-07-11 14:00:51 UTC 1296 followers, 1416 engagements


"$P&G teams with DTI to expand the 2025 vGROW Program empowering 60+ Filipino startups to tackle challenges in supply chain retail activations & digital commerce: #VGROW2025 #StartupPH #Innovation #DTI #Philippines"  
![@BioMedWire Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1275894206469267456.png) [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1944758946377416705) 2025-07-14 14:00:39 UTC 1295 followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioMedWire Avatar @BioMedWire BioMedWire

BioMedWire posts on X about $azn, $mrk, india, $tzup the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX +332%
  • X Month XXXXX +61%
  • X Months XXXXXX +34%
  • X Year XXXXXX +44%

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.23%
  • X Month XXXXX +0.39%
  • X Months XXXXX +0.70%
  • X Year XXXXX +0.54%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks countries currencies technology brands cryptocurrencies finance

Social topic influence $azn, $mrk, india, $tzup, microsoft, mounjaro, $lly, eli lilly, $beat, acquisition

Top assets mentioned AstraZeneca PLC (AZN) Merck & Co., Inc. (MRK) THUMZUP MEDIA CORP (TZUP) Microsoft Corp. (MSFT) Eli Lilly and Company (LLY) MetaBeat (BEAT)

Top Social Posts #


Top posts by engagements in the last XX hours

"AI System Beats Doctors at Diagnosing Complicated Health Conditions Microsoft Says $TZUP #AIstocks #Doctors"
@BioMedWire Avatar @BioMedWire on X 2025-07-07 15:15:12 UTC 1295 followers, XX engagements

"$LLY launches Mounjaro KwikPen in India a onceweekly prefilled injector offering six dosage strengths to help adults manage type2 diabetes and obesity: #Mounjaro #DiabetesCare #ObesityManagement #EliLilly"
@BioMedWire Avatar @BioMedWire on X 2025-06-26 18:00:19 UTC 1295 followers, XXX engagements

"$AZN secures CDSCO approval for Imfinzi (durvalumab) with gemcitabinecisplatin as neoadjuvant & adjuvant therapy in muscleinvasive bladder cancer patients in India: #BladderCancer #CDSCO #Oncology #Imfinzi"
@BioMedWire Avatar @BioMedWire on X 2025-07-15 18:00:19 UTC 1296 followers, XX engagements

"$AZN Baxdrostat has met both primary & secondary Phase III endpoints significantly lowering systolic BP in hardtotreat hypertension. Advancing a novel aldosteroneblocking therapy: #Baxdrostat #Hypertension #CardioRenal #AstraZeneca"
@BioMedWire Avatar @BioMedWire on X 2025-07-14 18:00:14 UTC 1296 followers, XX engagements

"$MRK begins clinical trials for MK-8527 a once-monthly oral HIV PrEP candidatepotential step forward in long-acting HIV prevention: #Merck #HIVPrevention #PrEP #ClinicalTrials #HealthcareInnovation"
@BioMedWire Avatar @BioMedWire on X 2025-07-15 14:00:38 UTC 1295 followers, XX engagements

"$MRK is set to begin Phase X trials for its once-monthly oral HIV prevention pill. A potential game-changer in long-acting PrEP options: #Merck #HIVPrevention #PrEP #HealthcareInnovation #PharmaNews"
@BioMedWire Avatar @BioMedWire on X 2025-07-16 14:00:39 UTC 1296 followers, XX engagements

"BioMedNewsBreaks Why $BEAT Is One to Watch"
@BioMedWire Avatar @BioMedWire on X 2025-07-08 19:19:12 UTC 1295 followers, XX engagements

"$AZN experimental drug for transthyretin amyloidosis did not meet its main goal in a late-stage trial dealing a setback in the race for rare disease treatments: #AstraZeneca #ClinicalTrials #PharmaNews #Biotech #HealthUpdate"
@BioMedWire Avatar @BioMedWire on X 2025-07-16 18:00:21 UTC 1296 followers, XX engagements

"$MRK has closed its $3.4B acquisition of SpringWorks Therapeutics expanding its oncology pipeline and bolstering precision cancer treatments: #MerckAcquisition #Oncology #PrecisionMedicine #PharmaNews #BioPharma"
@BioMedWire Avatar @BioMedWire on X 2025-07-11 14:00:51 UTC 1296 followers, 1416 engagements

"$P&G teams with DTI to expand the 2025 vGROW Program empowering 60+ Filipino startups to tackle challenges in supply chain retail activations & digital commerce: #VGROW2025 #StartupPH #Innovation #DTI #Philippines"
@BioMedWire Avatar @BioMedWire on X 2025-07-14 14:00:39 UTC 1295 followers, XX engagements

creator/x::BioMedWire
/creator/x::BioMedWire